These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cerebral metabolic effects of serotonin drugs and neurotoxins. Freo U Life Sci; 1996; 59(11):877-91. PubMed ID: 8795699 [TBL] [Abstract][Full Text] [Related]
5. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI. Baudrie V; Chaouloff F Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656 [TBL] [Abstract][Full Text] [Related]
7. The influence of corticosterone on serotonergic stereotypy and sexual behavior in the female rat. Hanson LA; Gorzalka BB Behav Brain Res; 1999 Oct; 104(1-2):27-35. PubMed ID: 11125740 [TBL] [Abstract][Full Text] [Related]
8. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. Dedeoğlu A; Fisher LA J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059 [TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats. Freo U; Pietrini P; Pizzolato G; Furey M; Merico A; Ruggero S; Dam M; Battistin L Neuropsychopharmacology; 1995 Nov; 13(3):215-22. PubMed ID: 8602894 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670 [TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats. Freo U; Larson DM; Soncrant TT Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044 [TBL] [Abstract][Full Text] [Related]
13. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Welch JE; Saphier D J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204 [TBL] [Abstract][Full Text] [Related]
14. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats. Freo U; Ricchieri GL; Holloway HW; Soncrant TT Brain Res; 1993 Jan; 600(2):249-56. PubMed ID: 8435750 [TBL] [Abstract][Full Text] [Related]
15. Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone. Gorzalka BB; Hanson LA Behav Brain Res; 1998 Dec; 97(1-2):143-51. PubMed ID: 9867239 [TBL] [Abstract][Full Text] [Related]
16. Blockade of corticosterone synthesis reduces serotonin turnover in the dorsal hippocampus of the rat as measured by microdialysis. Korte-Bouws GA; Korte SM; De Kloet ER; Bohus B J Neuroendocrinol; 1996 Nov; 8(11):877-81. PubMed ID: 8933365 [TBL] [Abstract][Full Text] [Related]
17. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Done CJ; Sharp T Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575 [TBL] [Abstract][Full Text] [Related]
18. Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats. Freo U; Ori C; Weiss SR; Perini GI J Neural Transm (Vienna); 2005 Nov; 112(11):1447-62. PubMed ID: 15843869 [TBL] [Abstract][Full Text] [Related]
19. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Alper RH Neuroendocrinology; 1990 Mar; 51(3):255-60. PubMed ID: 2109269 [TBL] [Abstract][Full Text] [Related]
20. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist. Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]